MCKESSON CORP

McKesson insider Lerman Bradley E. sells 301 shares after RSU vesting, a routine portfolio move amid strong earnings and positive sentiment.

CEO Tyler S. sells 8,463 McKesson shares—routine rule‑144 trading. Investors learn the sale’s impact, company fundamentals, and future insider‑trading signals.

CEO Ty Brion sells 4,929 McKesson shares under a 10b5‑1 plan— a routine move amid Q2 gains that signals disciplined governance and steady growth confidence.

Rodgers Thomas L’s recent 123‑share sale at McKesson signals disciplined insider liquidity amid a $1.25 billion Apollo investment, yet the company’s resilient health‑care distribution strategy keeps investors confident for the long term.

Explore MCKESSON CORP’s insider sales: LeAnn Smith’s recent 1,810‑share sale, its impact on stock trends, and what it signals for investors.

McKesson insider buying: CFO Kenny Cheung’s recent RSU purchase signals leadership confidence, hinting at upside potential amid a dip to the 52‑week low.

McKesson insider trades: Michele’s 3,550‑share sale follows a rule‑based pattern that shows management confidence but little impact on the stock.

McKesson insider trading: EVP Fraga Francisco’s mixed buy‑sell‑RSU moves signal confidence amid rising social media buzz, hinting at upcoming strategic shifts.

McKesson insider sale: EVP Lau Michele sells 303 shares under 10b5‑1, hinting at routine liquidity but raising investor curiosity about future confidence.

McKesson insider trades reveal strategic confidence: LeAnn Smith’s buys and sells near a 52‑week high signal cautious optimism while investors watch for tech‑driven growth.